My team and I developed a comprehensive business model for NuVax, a groundbreaking microneedle vaccine patch created by MECK Biotech. NuVax offers a painless, efficient way to administer vaccines while minimizing common side effects. Designed explicitly for mRNA-based influenza vaccines, the patch provides a more accessible and patient-friendly alternative to traditional vaccination methods.